Gretchen A. Cloud

12.3k total citations · 4 hit papers
95 papers, 8.4k citations indexed

About

Gretchen A. Cloud is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Gretchen A. Cloud has authored 95 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 37 papers in Infectious Diseases and 13 papers in Immunology. Recurrent topics in Gretchen A. Cloud's work include Fungal Infections and Studies (30 papers), Antifungal resistance and susceptibility (26 papers) and Cytomegalovirus and herpesvirus research (16 papers). Gretchen A. Cloud is often cited by papers focused on Fungal Infections and Studies (30 papers), Antifungal resistance and susceptibility (26 papers) and Cytomegalovirus and herpesvirus research (16 papers). Gretchen A. Cloud collaborates with scholars based in United States, United Kingdom and Canada. Gretchen A. Cloud's co-authors include William E. Dismukes, Michael S. Saag, Robert F. Pass, John R. Graybill, William G. Powderly, Carol A. Kauffman, Carmelita U. Tuazon, Peter G. Pappas, Richard J. Hamill and Sergio Stagno and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Gretchen A. Cloud

95 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1998 819 citations Gretchen A. Cloud, Michael S. Saag et al. profile →
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

1997 540 citations Michael S. Saag, Gretchen A. Cloud et al. New England Journal of Medicine profile →
Vaccine Prevention of Maternal Cytomegalovirus Infection

2009 527 citations Robert F. Pass, Tina Simpson et al. New England Journal of Medicine profile →
Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis

1992 470 citations Michael S. Saag, Gretchen A. Cloud et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gretchen A. Cloud United States	50	5.7k	5.1k	855	767	651	95	8.4k
Sebastian Lucas United Kingdom	47	3.7k 0.6×	3.7k 0.7×	557 0.7×	607 0.8×	754 1.2×	206	7.6k
Giampiero Carosi Italy	38	7.4k 1.3×	3.1k 0.6×	933 1.1×	485 0.6×	422 0.6×	164	10.7k
Constance A. Benson United States	49	4.2k 0.7×	5.7k 1.1×	3.1k 3.7×	487 0.6×	471 0.7×	182	9.4k
Graeme Meintjes South Africa	65	8.8k 1.5×	9.3k 1.8×	1.0k 1.2×	686 0.9×	368 0.6×	304	12.6k
Craig M. Wilson United States	46	2.4k 0.4×	3.3k 0.7×	1.4k 1.7×	865 1.1×	657 1.0×	194	7.7k
Lindsey R. Baden United States	56	5.0k 0.9×	5.9k 1.2×	700 0.8×	1.2k 1.6×	1.7k 2.6×	230	10.7k
Nathan Clumeck Belgium	50	6.4k 1.1×	5.9k 1.2×	4.3k 5.0×	698 0.9×	799 1.2×	238	12.7k
Donna Mildvan United States	45	3.9k 0.7×	5.3k 1.1×	3.7k 4.4×	1.5k 1.9×	526 0.8×	130	9.6k
John M. Leedom United States	29	3.0k 0.5×	3.9k 0.8×	2.2k 2.6×	495 0.6×	309 0.5×	75	6.3k
Stuart E. Starr United States	45	4.1k 0.7×	1.7k 0.3×	1.2k 1.4×	2.1k 2.8×	422 0.6×	140	6.5k

Countries citing papers authored by Gretchen A. Cloud

Since Specialization

Citations

This map shows the geographic impact of Gretchen A. Cloud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gretchen A. Cloud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gretchen A. Cloud more than expected).

Fields of papers citing papers by Gretchen A. Cloud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gretchen A. Cloud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gretchen A. Cloud. The network helps show where Gretchen A. Cloud may publish in the future.

Co-authorship network of co-authors of Gretchen A. Cloud

This figure shows the co-authorship network connecting the top 25 collaborators of Gretchen A. Cloud. A scholar is included among the top collaborators of Gretchen A. Cloud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gretchen A. Cloud. Gretchen A. Cloud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beck, Benjamin H., Martin R. Jadus, G. Yancey Gillespie, et al.. (2015). Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma. PLoS ONE. 10(5). e0122387–e0122387. 18 indexed citations

Kimberlin, David W., Mark J. Abzug, David J. Lang, et al.. (2010). Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age. The Pediatric Infectious Disease Journal. 29(3). 195–198. 32 indexed citations

Oliver, Sara E., Gretchen A. Cloud, Pablo J. Sánchez, et al.. (2009). Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. Journal of Clinical Virology. 46. S22–S26. 174 indexed citations

Pass, Robert F., Tina Simpson, William Andrews, et al.. (2009). Vaccine Prevention of Maternal Cytomegalovirus Infection. New England Journal of Medicine. 360(12). 1191–1199. 527 indexed citations breakdown →

Liu, Zhiyong, et al.. (2008). Protective Immunosurveillance and Therapeutic Antitumor Activity of γδ T Cells Demonstrated in a Mouse Model of Prostate Cancer. The Journal of Immunology. 180(9). 6044–6053. 98 indexed citations

Kimberlin, David W., Edward P. Acosta, Pablo J. Sánchez, et al.. (2008). Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus Disease. The Journal of Infectious Diseases. 197(6). 836–845. 196 indexed citations

Abzug, Mark J., Gretchen A. Cloud, John L. Bradley, et al.. (2003). . The Pediatric Infectious Disease Journal. 22(4). 335–340. 3 indexed citations

Chen, Ray Y., Andrew O. Westfall, James L. Raper, et al.. (2002). Immunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical Practice. AIDS Research and Human Retroviruses. 18(13). 909–916. 18 indexed citations

Wheat, L. Joseph, Gretchen A. Cloud, Philip C. Johnson, et al.. (2001). Clearance of Fungal Burden during Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B versus Itraconazole. Antimicrobial Agents and Chemotherapy. 45(8). 2354–2357. 63 indexed citations

10.

Goldman, M., Melinda Smedema, Patricia Connolly, et al.. (2001). DNA fingerprinting of serialCandida albicansisolates obtained during itraconazole prophylaxis in patients with AIDS. Medical Mycology. 39(2). 207–213. 3 indexed citations

11.

Call, Stephanie, Michael S. Saag, Andrew O. Westfall, et al.. (2001). Phenotypic Drug Susceptibility Testing Predicts Long‐Term Virologic Suppression Better than Treatment History in Patients with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 183(3). 401–408. 21 indexed citations

12.

Cloud, Gretchen A., Melinda Smedema, Ann M. LeMonte, et al.. (2000). Does Long-Term Itraconazole Prophylaxis Result in In Vitro Azole Resistance in Mucosal Candida albicans Isolates from Persons with Advanced Human Immunodeficiency Virus Infection?. Antimicrobial Agents and Chemotherapy. 44(6). 1585–1587. 63 indexed citations

13.

Whitley, R. J., Gretchen A. Cloud, William C. Gruber, et al.. (1997). Ganciclovir Treatment of Symptomatic Congenital Cytomegalovirus Infection: Results of a Phase II Study. The Journal of Infectious Diseases. 175(5). 1080–1086. 219 indexed citations

14.

Pappas, Peter G., Robert W. Bradsher, Carol A. Kauffman, et al.. (1997). Treatment of Blastomycosis with Higher Doses of Fluconazole. Clinical Infectious Diseases. 25(2). 200–205. 55 indexed citations

15.

Pappas, P. G., Robert W. Bradsher, Stanley W. Chapman, et al.. (1995). Treatment of Blastomycosis with Fluconazole: A Pilot Study. Clinical Infectious Diseases. 20(2). 267–271. 60 indexed citations

16.

Ampel, Neil M., et al.. (1995). Tumor Necrosis Factor- and Interleukin-1 in Cerebrospinal Fluid of Patients with Coccidioidal Meningitis during Therapy with Fluconazole. The Journal of Infectious Diseases. 171(6). 1675–1678. 7 indexed citations

17.

Hostetler, J.S., Antonino Catanzaro, David A. Stevens, et al.. (1994). Treatment of coccidioidomycosis with SCH 39304. Medical Mycology. 32(2). 105–114. 10 indexed citations

18.

Oh, M. Kim, et al.. (1989). Chlamydia trachomatis cervical infection and oral contraceptive use among adolescent girls. Journal of Adolescent Health Care. 10(5). 376–381. 22 indexed citations

19.

Brumfield, Cynthia G., Gretchen A. Cloud, Sara Finley, et al.. (1987). Amniotic fluid α-fetorotein levels and pregnancy outcome. American Journal of Obstetrics and Gynecology. 157(4). 822–825. 6 indexed citations

20.

Lamon, E W, et al.. (1982). Complementation between Infecting Epstein-Barr Virus and Intrinsic Viral Genomes in Human Lymphoid Cell Lines. Intervirology. 18(1-2). 66–75. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact